Market Overview - On January 5, the Shanghai Composite Index rose by 1.38%, with the total margin trading balance reaching 25,606.48 billion yuan, an increase of 199.66 billion yuan compared to the previous trading day [1] - The margin trading balance in the Shanghai market was 12,886.02 billion yuan, up by 86.86 billion yuan, while the Shenzhen market's balance was 12,639.08 billion yuan, increasing by 111.09 billion yuan [1] Industry Analysis - Among the industries tracked by Shenwan, 27 sectors saw an increase in margin trading balances, with the electronics sector leading, increasing by 33.50 billion yuan [1] - Other notable sectors included non-ferrous metals and machinery equipment, which saw increases of 25.87 billion yuan and 23.70 billion yuan, respectively [1] Stock Performance - A total of 2,310 stocks experienced an increase in margin trading balances, accounting for 61.34% of the market, with 537 stocks showing an increase of over 5% [1] - The stock with the highest increase in margin trading balance was Jinhao Medical, which saw a balance of 28.89 million yuan, up by 524.19% from the previous trading day, and its stock price rose by 20.03% [1] - Other significant performers included Henghe Co. and Zhite New Materials, with increases of 105.36% and 67.98% in margin trading balances, respectively [1] Top Gainers in Margin Trading - The top 20 stocks with the highest increase in margin trading balances averaged a rise of 7.48%, with Zhite New Materials, Jinhao Medical, and Xice Testing leading with increases of 20.04%, 20.03%, and 20.00%, respectively [2] Decliners in Margin Trading - In contrast, 1,456 stocks saw a decrease in margin trading balances, with 178 stocks declining by more than 5% [4] - The stock with the largest decrease was Cuiwei Co., with a margin trading balance of 30.6 million yuan, down by 30.18% [5] - Other notable decliners included Southern Pump Industry and Tianming Technology, with decreases of 23.67% and 23.22%, respectively [4]

Group 1 - The core stock price of JinHao Medical (920925) closed at 38.23 yuan on January 5, 2026, with an increase of 20.03% and a turnover rate of 19.58%, resulting in a trading volume of 108,300 lots and a transaction amount of 394 million yuan [1] - On January 5, the net inflow of main funds was 84.54 million yuan, accounting for 21.44% of the total transaction amount, while retail investors had a net inflow of 1.80 million yuan, representing 0.46% of the total transaction amount [2][4] - JinHao Medical was listed among the top 5 stocks on the Dragon and Tiger List due to its closing price increase of 20% on January 5, marking its first appearance on the list in the past 5 trading days [3][4]

Group 1 - The stock of JinHao Medical (920925) increased by 20.03% today, with a turnover rate of 19.58% and a total transaction amount of 394 million yuan, showing a volatility of 29.18% [1] - The stock was listed on the exchange due to its daily price fluctuation reaching 20.03%, with a total net selling amount of 16.5892 million yuan from brokerage seats [2] - The top five brokerage seats accounted for a total transaction of 120 million yuan, with a buying amount of 51.5093 million yuan and a selling amount of 68.0984 million yuan, resulting in a net selling of 16.5892 million yuan [2] Group 2 - The largest buying brokerage was Huatai Securities Co., Ltd. Shenzhen Qianhai Securities, with a buying amount of 13.12 million yuan, while the largest selling brokerage was Debon Securities Co., Ltd. Shanghai Zhengli Road Securities, with a selling amount of 15.5407 million yuan [2] - Detailed trading information shows that the top five buying brokerages had no selling amounts, while the top five selling brokerages had significant selling amounts, indicating a strong selling pressure [2]

Summary of Key Points Core Viewpoint The trading volume and value of stocks on the Beijing Stock Exchange (BSE) showed a significant increase on January 5, with a total trading volume of 803 million shares and a total trading value of 21.188 billion yuan, marking an increase of 474 million yuan compared to the previous trading day. The majority of stocks experienced price increases, indicating a positive market sentiment. Trading Performance - The total trading volume on the BSE reached 803 million shares, with a trading value of 21.188 billion yuan, an increase of 474 million yuan from the previous day [1] - A total of 226 stocks closed higher, accounting for 79.02% of the tradable stocks, with notable gainers including KaiDe Quartz (up 22.36%), JinHao Medical (up 20.03%), and HengDong Light (up 12.94%) [1] - Conversely, 57 stocks closed lower, with TianMing Technology, JiaXian Co., and LiFang Holdings experiencing the largest declines of 15.03%, 10.33%, and 8.46% respectively [1] Active Stocks - 56 stocks had a trading value exceeding 100 million yuan, with HengDong Light leading at 1.909 billion yuan, followed by XingTu Measurement Control at 736 million yuan and KaiDe Quartz at 477 million yuan [1] - The trading activity was robust, with 23 stocks having a turnover rate exceeding 10%, and 5 stocks exceeding 20% [1] - The stocks with the highest turnover rates included DaPeng Industrial (28.25%), HengDong Light (27.83%), and ChenGuang Medical (24.13%) [1] Notable Stock Data - The closing prices and performance of key stocks included: - HengDong Light: 348.99 yuan, up 12.94%, turnover rate 27.83%, trading value 1.909 billion yuan [1] - XingTu Measurement Control: 90.50 yuan, up 7.10%, turnover rate 19.74%, trading value 736 million yuan [1] - KaiDe Quartz: 47.28 yuan, up 22.36%, turnover rate 18.24%, trading value 477 million yuan [1]

Group 1 - The core point of the article is that JinHao Medical (stock code: 920925) experienced a significant price increase of 20.03% on January 5, 2026, leading to its appearance on the stock market's "Dragon and Tiger List" [1][3] - The trading volume for JinHao Medical on that day reached 10.8265 million shares, with a total transaction value of 394 million yuan [1][2] - The top buying position was held by Huatai Securities Co., Ltd. with a purchase amount of approximately 13.12 million yuan, while the top selling position was held by Debon Securities Co., Ltd. with a selling amount of approximately 15.54 million yuan [1][2] Group 2 - The article provides detailed trading data, including the top five buying and selling brokerage firms, highlighting significant transactions from various securities companies [2] - Notably, the second-largest buying position was from China Galaxy Securities with approximately 11.51 million yuan, and the third from Dongfang Securities with about 10.48 million yuan [2] - On the selling side, the second-largest selling position was from Guosen Securities with approximately 15.24 million yuan, indicating a competitive trading environment [2]

Group 1 - The medical device sector experienced a significant increase of 5.5% on January 5, with JinHao Medical leading the gains [1] - The Shanghai Composite Index closed at 4023.42, up 1.38%, while the Shenzhen Component Index closed at 13828.63, up 2.24% [1] - Notable individual stock performances included JinHao Medical with a closing price of 38.23, up 20.03%, and BoTuo Bio with a closing price of 45.34, also up 20.01% [1] Group 2 - The medical device sector saw a net inflow of 1.678 billion yuan from institutional investors, while retail investors experienced a net outflow of 644 million yuan [2] - The top individual stock in terms of net inflow was AiPeng Medical, with a net inflow of 1.57 million yuan, representing 25.59% of its trading volume [3] - Conversely, major outflows were observed in stocks like MaiRui Medical, which had a net outflow of 91.39 million yuan from retail investors, accounting for 2.74% of its trading volume [3]

证券代码：920925 证券简称：锦好医疗 公告编号：2025-136 惠州市锦好医疗科技股份有限公司 关于使用部分闲置自有资金购买理财产品的进展公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 授权委托理财情况 （一）购买理财产品的审议情况 惠州市锦好医疗科技股份有限公司（以下简称"公司"）于 2025 年 10 月 27 日召开第三届董事会第十七次会议审议通过《关于使用部分闲置自有资金购买银 行理财产品的议案》。为提高公司资金使用效率，在确保资金安全、不影响公司 正常经营的前提下，公司合理利用部分暂时闲置自有资金购买银行理财产品。使 用额度不超过人民币 10,000 万元的自有闲置资金购买安全性高、流动性好、风 险较低的理财产品，在此额度内可以循环滚动使用。具体内容详见公司 2025 年 10 月 29 日在北京证券交易所（www.bse.cn）披露的《关于使用部分闲置自有资 金购买银行理财产品的公告》（公告编号：2025-122）。 （二）购买理财产品的披露标准 根据《北京证券交易所股票 ...

Market Overview - The medical device sector experienced a decline of 0.74% on December 29, with Huakang Clean leading the drop [1] - The Shanghai Composite Index closed at 3965.28, up 0.04%, while the Shenzhen Component Index closed at 13537.1, down 0.49% [1] Top Performers - Meihao Medical (301363) saw a closing price of 25.04, with an increase of 8.30% and a trading volume of 197,100 shares, totaling a transaction value of 482 million yuan [1] - Mailande (688273) closed at 41.73, up 8.22%, with a trading volume of 55,200 shares and a transaction value of 227 million yuan [1] - Kangzhong Medical (688607) closed at 45.80, up 7.23%, with a trading volume of 40,200 shares and a transaction value of 180 million yuan [1] Underperformers - Huakang Clean (301235) closed at 39.21, down 8.54%, with a trading volume of 123,300 shares and a transaction value of 488 million yuan [2] - C Jianxin (688805) closed at 47.16, down 7.26%, with a trading volume of 89,000 shares and a transaction value of 426 million yuan [2] - Furuim Medical (300049) closed at 71.93, down 4.20%, with a trading volume of 66,800 shares and a transaction value of 485 million yuan [2] Capital Flow - The medical device sector saw a net outflow of 565 million yuan from institutional investors, while retail investors experienced a net inflow of 328 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors are more active [2] Individual Stock Capital Flow - Meihao Medical (301363) had a net outflow of 54.30 million yuan from institutional investors, with retail investors also showing a net outflow of 0.76 million yuan [3] - Jigaofazhan (600807) experienced a net inflow of 44.75 million yuan from institutional investors, while retail investors had a net outflow of 61.29 million yuan [3] - Kangzhong Medical (688626) saw a net inflow of 44.26 million yuan from institutional investors, with retail investors showing a slight net outflow [3]

Market Overview - The medical device sector increased by 1.35% on December 25, with Sainuo Medical leading the gains [1] - The Shanghai Composite Index closed at 3959.62, up 0.47%, while the Shenzhen Component Index closed at 13531.41, up 0.33% [1] Top Performers - Sainuo Medical (688108) closed at 20.43, up 14.90%, with a trading volume of 609,800 shares and a transaction value of 1.22 billion [1] - Jinhao Medical (920925) closed at 33.03, up 12.81%, with a trading volume of 38,400 shares [1] - Mailland (688273) closed at 40.38, up 12.07%, with a trading volume of 54,800 shares [1] - Tianchen Medical (688013) closed at 52.94, up 11.10%, with a trading volume of 31,200 shares [1] - Xiangyu Medical (688626) closed at 57.47, up 6.80%, with a trading volume of 53,400 shares [1] Underperformers - C Jianxin (688805) closed at 53.31, down 8.28%, with a trading volume of 142,100 shares and a transaction value of 754 million [2] - Tianyi Medical (301097) closed at 51.89, down 5.43%, with a trading volume of 18,800 shares [2] - Hualan Co. (301093) closed at 49.54, down 2.75%, with a trading volume of 39,000 shares [2] Capital Flow - The medical device sector saw a net inflow of 137 million from institutional investors, while retail investors experienced a net inflow of 65.58 million [2] - The sector's main funds saw a net outflow of 203 million from speculative funds [2] Individual Stock Capital Flow - Sainuo Medical had a net inflow of 117 million from main funds, but a net outflow of 98.09 million from retail investors [3] - Zhend Medical (603301) had a net inflow of 85.32 million from main funds, with a net outflow of 76.17 million from retail investors [3] - Huakang Clean (301235) had a net inflow of 65.37 million from main funds, with a net outflow of 64.32 million from retail investors [3]

证券代码：920925 证券简称：锦好医疗 公告编号：2025-133 惠州市锦好医疗科技股份有限公司 拟续聘 2025 年度会计师事务所公告 （一）机构信息 公司拟聘任大信会计师事务所（特殊普通合伙）为 2025 年年度的审计机构。 1.基本信息 会计师事务所名称：大信会计师事务所（特殊普通合伙） 成立日期：2012 年 3 月 6 日 首席合伙人：谢泽敏 2024 年度末签署过证券服务业务审计报告的注册会计师人数：500 人 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 涉及会计师事务所提供的资料、信息，会计师事务所保证其提供、报送或披 露的资料、信息真实、准确、完整，不得有虚假记载、误导性陈述或者重大遗漏。 一、拟续聘会计师事务所的基本情况 2024 年收入总额（经审计）：15.75 亿元 2024 年审计业务收入（经审计）：13.78 亿元 2024 年证券业务收入（经审计）：4.05 亿元 2024 年上市公司审计客户家数：221 家（含 H 股） 2024 年上市公司审计客户前五大主要行业 ...